Search

everythinglearnresearchcommunity

for

Search:↓

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Both human platelet lysate and minoxidil can promote hair growth, but they affect different genes and cell survival rates.

Researchers found 44 proteins that change during different hair growth stages and may be important for hair follicle function.

Minoxidil helps hair growth by activating the β-catenin pathway.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride may improve prostate cancer treatment outcomes.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Stopping finasteride improves sperm quality but not semen volume in young men.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

CT scans can find serious prostate cancer even when PSA levels are low.

Mouse genital development depends on male or female hormones for specific features.